MAPK3 and pancreatic adenocarcinoma: IHC for phospho ERK1/2 of invasive pancreatic adenocarcinoma from Pc1Pik3cap110* mice treated with vehicle alone or NVP-BEZ235 for 6 h or 4 days was performed (Figures 6c and d, respectively).